GGI
GILD icon

Godsey & Gibb Inc’s Gilead Sciences GILD Stock Holding History

Godsey & Gibb Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.49K Buy
+10
New +$1.4K ﹤0.01% 398
2024
Q1 		– Sell
-600
Closed -$48.6K – 397
2023
Q4 		$48.6K Buy
+600
New +$46.7K 0.01% 164
2023
Q1 		– Sell
-20
Closed -$1.72K – 361
2022
Q4 		$1.72K Buy
+20
New +$1.58K ﹤0.01% 269

Other funds holding GILD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return

Godsey & Gibb Inc's GILD Position: Q3 2026 in Review

Godsey & Gibb Inc opened a new position in Gilead Sciences (GILD) in Q3 2026: 10 shares worth $1.49K. The stake represents ﹤0.01% of the portfolio and ranks #398 among its holdings. This is a return to the name: Godsey & Gibb Inc previously reported a position in GILD as recently as Q4 2023.

Godsey & Gibb Inc first reported a position in GILD in Q4 2022 and has held it in 3 quarters since. The position peaked at $48.6K in Q4 2023. 338 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Godsey & Gibb Inc held 10 shares of Gilead Sciences worth $1.49K as of Q3 2026.
  • Gilead Sciences was a new Godsey & Gibb Inc position in Q3 2026.
  • Gilead Sciences made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q3 2026, its #398 holding.
  • Godsey & Gibb Inc first reported a position in Gilead Sciences in Q4 2022 and has held it in 3 quarters since.
  • Godsey & Gibb Inc's Gilead Sciences position peaked at $48.6K in Q4 2023.
  • 338 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Godsey & Gibb Inc's 13F filing for Q3 2026, filed 14 Oct 2026.